PREVALENCE AND RISK FACTORS OF OSTEOPOROSIS AND VERTEBRAL FRACTURES IN COPD MALES
E. Casado1, M. Gallego2, M. Larrosa1, C. Orellana1, R. Valls3, E. Berlanga4, C. Domingo2, J. Gratacòs1
1Rheumatology, Hospital Sabadell, Sabadell, Spain, 2Pneumology, Hospital Sabadell, Sabadell, Spain, 3Radiology, UDIAT, Sabadell, Spain, 4Laboratory, UDIAT, Sabadell, Spain.
BOTH N- AND C-TERMINAL FRAGMENTS OF PTHRP EXERT PRO-SURVIVAL EFFECTS ON HUMAN PROSTATE CANCER CELLS THROUGH TRANSCRIPTION FACTOR RUNX-2
V. Alonso1, F. C. Pérez-Martínez2, F. J. Calahorra2, P. Esbrit1
1Bone and Mineral Metabolism Laboratory, Fundación Jiménez Díaz, Madrid, Spain, 2Urology Department, Fundación Jiménez Díaz, Madrid, Spain.
RISK FACTORS FOR OSTEOPOROSIS AND FRAGILITY FRACTURES IN POSTMENOPAUSAL WOMEN AND MEN OLDER THAN 50 ATTENDED IN A PRIMARY CARE CENTER OF SPAIN. THE CAMARGO COHORT STUDY
J.M. Olmos1, C. Ramos2, J.L. Hernández1, P. García2, J. Martínez1, J de Juan2, D. Nan1, C Valero1, J González Macías1
1Department of Internal Medicine, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria. Santander, Spain. 2 Centro de Salud "José Barros". Camargo. Universidad de Cantabria. Santander, Spain.
STATINS DECREASE BONE TURNOVER MARKERS IN POSTMENOPAUSAL WOMEN
J. Martínez1, J.L. Hernández1, J.M. Olmos1, E. Pariente2, C. Valero1, P. García2, D. Nan1, G. Pinedo2, J. González Macías1
1Department of Internal Medicine, Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria. Santander, Spain. 2Centro de Salud "José Barros". Camargo. Universidad de Cantabria. Santander, Spain.
INTAKE OF CALCIUM AND OTHER MINERALS THROUGH WATER: HEALTH IMPLICATIONS
M.A. Martínez-Ferrer, P. Peris, R. Reyes, N. Guañabens
Service of Rheumatolgy. Hospital Clínic. University of Barcelona.
EFFECT OF RISEDRONATE ON BONE LOSS ASSOCIATED WITH LIVER TRANSPLANTATION
S. Guadalix1, M. Gomez-Juaristi1, G. Martinez2, C. Vargas3, J. Meneu4, A. de Lozar3, E. Jodar1, E. Moreno4, F. Hawkins1
1Endocrinology Service, University Hospital 12 de Octubre, Madrid, Spain, 2University Hospital 12 de Octubre, Madrid, Spain, 3Biochemistry Service, University Hospital 12 de Octubre, Madrid, Spain, 4Digestive Surgery, University Hospital 12 de Octubre, Madrid, Spain.
OSTEPROTEGERIN AS CARDIOVASCULAR RISK MARKER IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
P. Rozas-Moreno, M. Muñoz-Torres, G. Alonso, D. Fernández-García, I. Luque-Fernández, A. Sebastian-Ochoa y F. Escobar-Jiménez
Endocrinology Service, University Hospital San Cecilio, Granada, Spain
Agradecemos la colaboración a: Lilly, Novartis, Nycomed, Procter&Gamble, Roche/GSK y Servier